Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - SPECTRANETICS CORPex99-1fdaclearance.htm


 
 
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  November 12, 2015
 
The Spectranetics Corporation
(Exact name of registrant as specified in its charter)
 
 
Delaware
 
000-19711
 
84-0997049
 
 
(State or other jurisdiction
 
(Commission
 
(IRS Employer
 
 
of incorporation)
 
File Number)
 
Identification No.)
 
 
9965 Federal Drive
Colorado Springs, Colorado 80921
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (719) 633-8333
 
(Former name or former address, if changed since last report.)
  
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  
 
 
 
 
 





Item 8.01    Other Events.

On November 12, 2015, The Spectranetics Corporation issued a press release regarding FDA clearance for its Turbo-Power Laser Atherectomy Catheter.  A copy of the press release is filed as Exhibit 99.1 and is incorporated herein by reference.
 

Item 9.01     Financial Statements and Exhibits.

(d) Exhibits
Exhibit No.
Description
 
 
99.1
Press release issued by The Spectranetics Corporation on November 12, 2015



2




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
THE SPECTRANETICS CORPORATION
 
 
(registrant)
 
 
 
 
 
 
Date:
November 13, 2015
By:
/s/ Jeffrey A. Sherman
 
 
 
Jeffrey A. Sherman
 
 
 
Vice President, Deputy General Counsel and Corporate Secretary
 
 
 
 
 








3




 
EXHIBIT INDEX
 

Exhibit No.
Description
 
 
99.1
Press release issued by The Spectranetics Corporation on November 12, 2015





4